-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
October 01, 2016 - Conclusions with strength of evidence for an effect or lack of effect (continued)
14
Outcome Intervention … Conclusions with strength of evidence for an effect or lack of effect (continued)
15
Outcome Intervention … Conclusions with strength of evidence for an effect or lack of effect (continued)
16
Outcome Intervention … Conclusions with strength of evidence for an effect or lack of effect (continued)
17
Outcome Intervention … Conclusions with strength of evidence for an effect or lack of effect (continued)
aFigures represent
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
March 01, 2016 - Long term observational
extension studies from these RCTs show that patients who
continued on pharmaceutical … less, since in the one RCT of urate lowering
therapy where prophylactic colchicine or NSAIDs were
continued … Summary of prior knowledge, findings from the systematic review,
and strength of evidence, by KQ (continued … Summary of prior knowledge, findings from the systematic review,
and strength of evidence, by KQ (continued … Summary of prior knowledge, findings from the systematic review,
and strength of evidence, by KQ (continued
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2010_research-protocol.pdf
January 01, 2010 - With continued administration, it is expected that the treatment regimen will make the patient tolerant … immunotherapy, recognized its potential as a viable alternative to subcutaneous therapy, and encouraged
continued … Long-term outcomes
a) Evidence for sustained clinical benefit with continued treatment (maintenance … capability of SIT to result in remission of the disease entity itself; this may be manifest as an effect of continued … Maintenance control: capability of SIT to provide sustained clinical benefit with continued use.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_disposition-comments.pdf
July 14, 2016 - Response
Results Phyllis
Foxworth
(Depression
and Bipolar
Support
Alliance)
Key Questions [continued … General Phyllis
Foxworth
(Depression
and Bipolar
Support
Alliance)
Recommendations [continued] … Response
General Phyllis
Foxworth
(Depression
and Bipolar
Support
Alliance)
Recommendations [continued
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
September 01, 2007 - Leadership: Continued leadership is necessary to maintain and manage an incident reporting
system and … Critical Success Factors
5.1 Factors Influencing Pharmacy Participation
The successful adoption and continued … hypothesize that while organizational buy-in is necessary for initial
adoption of a new system, its continued
-
effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
September 01, 2007 - Leadership: Continued leadership is necessary to maintain and manage an incident reporting
system and … Critical Success Factors
5.1 Factors Influencing Pharmacy Participation
The successful adoption and continued … hypothesize that while organizational buy-in is necessary for initial
adoption of a new system, its continued
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder_executive.pdf
December 01, 2015 - Inclusion/exclusion criteria (continued)
Criteria Inclusion Exclusion
Interventions
(continued)
Other … Inclusion/exclusion criteria (continued)
Criteria Inclusion Exclusion
Outcomes • Benefits: response
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
June 04, 2010 - First generation antipsychotics included in the CER (continued)
Generic name Trade names(s) Mode of … First generation antipsychotics: FDA status (continued)
Drug FDA status Indications Age group approved … Second generation antipsychotics: FDA status (continued)
Drug FDA status (year
approved)
Indications
-
effectivehealthcare.ahrq.gov/sites/default/files/grama.pdf
May 29, 2025 - Using Collaborative Platforms for Communities of Practice
INNOVATIONS CONFERENCE -- NATIONAL CANCER INSTITUTE
SPEAKER: LAKSHMI GRAMA,
SENIOR DIGITAL CONTENT STRATEGIST,
NATIONAL CANCER INSTITUTE (NCI)
GRAMA: I’m Lakshmi Grama from the Office of Communications and
Education at the National …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_surveillance.pdf
April 01, 2012 - AHRQ Comparative Effectiveness Review
Surveillance Program
CER #32:
Diagnosis and Treatment of Obstructive Sleep Apnea
in Adults
Original release date:
August 8, 2011
Surveillance Report:
July, 2012
Key Findings:
- The conclusions for KQ2 (phased testing), KQ3
(preoperative screening), KQ6 (compliance…
-
effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_media_wilkes.ppt
April 01, 2006 - Instead, the reporting is sensationalized:
Sensationalism continued…
The journalist overstates a
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/deliberative-methods_presentation-2013.pdf
January 01, 2013 - This encouraged continued discussion and open-ended responses to polling
questions.
16
The
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_clinician.pdf
July 01, 2016 - Overview of Clinical Research Evidence (Continued)
Table 2: Adverse Effects Associated With Interventions
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/saturated-fat-replacement-protocol.pdf
January 01, 2024 - Dietary Saturated Fat Replacement and Plasma Lipid and Cardiovascular Events
Evidence-based Practice Center Systematic Review Protocol
Project Title: Dietary Saturated Fat Replacement and Plasma Lipid and
Cardiovascular Events
I. Background and Purpose of the Systematic Review
Background
The fatt…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
February 01, 2017 - of EBRT and no extra toxicity.17
Bisphosphonates and EBRT
The updated literature review highlights continued
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth-future_research.pdf
August 09, 2012 - Finally, we thank Mark Helfand,
M.D., M.P.H., for his insights and continued support. … Both the systematic review and the Conference revealed that VBAC rates continued to
decline despite … Phase 2, Delphi round 1: detailed responses (continued)
Question a
High
(%) (n)
Medium
(%) (n) … Phase 2, Delphi round 1: detailed responses (continued)
Question a
High
(%) (n)
Medium
(%) (n) … Future research agenda for vaginal birth after cesarean (continued)
Ranked Priority Research Area
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
January 01, 2010 - In this example, continued exposure
improves the effectiveness of the intervention,
but when the intervention … Continued
exposure to oral corticosteroids may continue to
increase the risk of fracture associated
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/quality-gap-palliative-hospice_disposition-comments.pdf
October 01, 2012 - Improving Health Care and Palliative Care for Advanced and Serious Illness Disposition of Comments Report
Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=1303
Published Online: October 2012.
Comparative Effectiveness Research Review Dis…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_disposition-comments.pdf
September 01, 2011 - Ananth et al6, in viewing over 17 million
births from 1990-99 found that while deliveries <37 weeks continued … Peer Reviewer 2 Discussion/
Conclusion
I would like to see a comment added that its continued use should
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-245-breast-reconstruction-after-mastectomy-evidence-summary-updated-1.pdf
October 01, 2021 - Continued on page 2
2
Background and Purpose
Breast cancer is the most common new cancer diagnosis